Citations

Showing 10 of 108094 citations.

Editorial: transplantation in the setting of acute‐on‐chronic liver failure—calculating chances
Izzy, Manhal , Watt, Kymberly D. , Izzy, M , Watt, K D

Mayo Clinic

Alimentary Pharmacology & Therapeutics | June 8, 2018 | Volume: 48 | Issue: 1 | Pages: 99-100

10.1111/apt.14679 | PMID 29882980 Get It

Linked ContentThis article is linked to Huebener et al papers. To view these articles visit https://doi.org/10.1111/apt.14627 and https://doi.org/10.1111/apt.14804.
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Walker, Brian A. , Mavrommatis, Konstantinos , Wardell, Christopher P. , Ashby, Cody , Bauer, Michael , Davies, Faith E. , Hoering, Antje , Samur, Mehmet , Towfic, Fadi , Flynt, Erin , Yu, Zhinuan, Yang, Zhihong, Rozelle, Dan , Obenauer, John C. , Trotter, Matthew , Auclair, Daniel , Keats, Jonathan J. , Bolli, Niccolò , Fulciniti, Mariateresa , Szalat, Raphaël , Moreau, Philippe , Durie, Brian G.M. , Stewart, A. Keith, Goldschmidt, Hartmut , Sonneveld, Pieter , Miguel, Jesús F. San , Jackson, Graham , Avet‐Loiseau, Hervé , Munshi, Nikhil , Thakurta, Anjan , Morgan, Gareth J. , Moreau, Philippe , Bolli, Niccolo' , San-Miguel, Jesus , Davies, Faith E , Keats, Jonathan J , Walker, Brian A , Morgan, Gareth J , Rosenthal, Adam , Wang, Hongwei , Qu, Pingping , Ortiz, María , Raab, Marc S. , Einsele, Hermann , Lonial, Sagar , Anderson, Kenneth C. , Flynt, Erin , Samur, Mehmet K , Szalat, Raphael

Mayo Clinic

Blood | June 8, 2018 | Volume: 132 | Issue: 6 | Pages: 587-597

10.1182/blood-2018-03-840132 | PMID 29884741 Get It

Key Points Using the largest set of patients with newly diagnosed myeloma, we identified 63 mutated driver genes. We identified oncogenic dependencies, particularly relating to primary translocations, indicating a nonrandom accumulation of genetic hits.
Vagal nerve stimulation for intractable hiccups is not a panacea: a case report and review of the literature
Grewal, Sanjeet S. , Adams, Andrea C., Grewal, Sanjeet , Gompel, Jamie J. Van

Mayo Clinic

International Journal of Neuroscience | June 8, 2018 | Volume: 128 | Issue: 12 | Pages: 1114-1117

10.1080/00207454.2018.1486307 | PMID 29882681 Get It

Influenza vaccine failure: failure to protect or failure to understand?
Poland, Gregory A.

Mayo Clinic

Expert Review of Vaccines | June 8, 2018 | Volume: 17 | Issue: 6 | Pages: 495-502

10.1080/14760584.2018.1484284 | PMID 29883218 Get It

Complications following pediatric cranioplasty after decompressive craniectomy: a multicenter retrospective study
Rocque, Brandon G. , Agee, Bonita S. , Thompson, Eric M. , Piedra, Mark, Baird, Lissa , Greene, Stephanie , Deibert, Christopher P., Hankinson, Todd C. , Lew, Sean M. , Iskandar, Bermans J. , Bragg, Taryn, Frim, David M. , Gupta, Nalin , Auguste, Kurtis I. , Nikas, Dimitrios C., Vassilyadi, Michael, Muh, Carrie R. , Wetjen, Nicholas M. , Lam, Sandi , Selden, Nathan R. W. , Grant, Gerald A. , Muh, Carrie R

Mayo Clinic

Journal of Neurosurgery: Pediatrics | June 8, 2018 | Volume: 22 | Issue: 3 | Pages: 225-232

10.3171/2018.3.peds17234 | PMID 29882736 Get It

OBJECTIVEIn children, the repair of skull defects arising from decompressive craniectomy presents a unique set of challenges. Single-center studies have identified different risk factors for the common complications of cranioplasty resorption and infection. The goal of the present study was to determine the risk factors for bone resorption and infection after pediatric cranioplasty.METHODSThe authors conducted a multicenter retrospective case study that included all patients who underwent cranioplasty to correct a skull defect arising from a decompressive craniectomy at 13 centers between 2000 and 2011 and were less than 19 years old at the time of cranioplasty. Prior systematic review of the literature along with expert opinion guided the selection of variables to be collected. These included: indication for craniectomy; history of abusive head trauma; method of bone storage; method of bone fixation; use of drains; size of bone graft; presence of other implants, including ventriculoperitoneal (VP) shunt; presence of fluid collections; age at craniectomy; and time between craniectomy and cranioplasty.RESULTSA total of 359 patients met the inclusion criteria. The patients’ mean age was 8.4 years, and 51.5% were female. Thirty-eight cases (10.5%) were complicated by infection. In multivariate analysis, presence of a cranial implant (primarily VP shunt) (OR 2.41, 95% CI 1.17–4.98), presence of gastrostomy (OR 2.44, 95% CI 1.03–5.79), and ventilator dependence (OR 8.45, 95% CI 1.10–65.08) were significant risk factors for cranioplasty infection. No other variable was associated with infection.Of the 240 patients who underwent a cranioplasty with bone graft, 21.7% showed bone resorption significant enough to warrant repeat surgical intervention. The most important predictor of cranioplasty bone resorption was age at the time of cranioplasty. For every month of increased age the risk of bone flap resorption decreased by 1% (OR 0.99, 95% CI 0.98–0.99, p < 0.001). Other risk factors for resorption in multivariate models were the use of external ventricular drains and lumbar shunts.CONCLUSIONSThis is the largest study of pediatric cranioplasty outcomes performed to date. Analysis included variables found to be significant in previous retrospective reports. Presence of a cranial implant such as VP shunt is the most significant risk factor for cranioplasty infection, whereas younger age at cranioplasty is the dominant risk factor for bone resorption.
Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications
Frazee, Erin N. , Voils, Stacy A. , Kane‐Gill, Sandra L. , Frazee, Erin N , Kane-Gill, Sandra L , Rule, Andrew D.

Mayo Clinic

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | June 8, 2018 | Volume: 38 | Issue: 8 | Pages: 794-803

10.1002/phar.2149 | PMID 29883532 Get It

Over the last decade, the discovery of novel renal biomarkers and research on their use to improve medication effectiveness and safety has expanded considerably. Pharmacists are uniquely positioned to leverage this new technology for renal assessment to improve medication dosing and monitoring. Serum cystatin C is a relatively new, inexpensive, functional renal biomarker that responds more quickly to changing renal function than creatinine and is not meaningfully affected by age, sex, skeletal muscle mass, dietary intake, or deconditioning. Cystatin C has been proposed as an adjunct or alternative to creatinine for glomerular filtration rate assessment and estimation of drug clearance. Tissue inhibitor of metalloproteinase‐2·insulin‐like growth factor‐binding protein 7 ([TIMP‐2]·[IGFBP7]) is a composite of two damage biomarkers released into the urine at a checkpoint in mitosis when renal cells undergo stress or sense a future risk of damage. Concentrations of [TIMP‐2]·[IGFBP7] increase before a rise in serum creatinine is evident, thus providing insightful information for evaluation in the context of other patient data to predict the risk for impending kidney injury. This article provides a brief overview of novel renal biomarkers being used as a mechanism to improve medication safety including a discussion of cystatin C, as part of drug‐dosing algorithms and specifically for vancomycin dosing, and the use of [TIMP‐2]·[IGFBP7] for risk prediction in acute kidney injury and drug‐induced kidney disease. Select cases of clinical experience with novel renal biomarkers are outlined, and lessons learned and future applications are described.
CT for Evaluation of Acute Gastrointestinal Bleeding
Wells, Michael , Bruining, David H. , Fletcher, Joel G. , Froemming, Adam T. , Barlow, John M. , Fidler, Jeff L. , Wells, Michael L, Hansel, Stephanie L. , Fletcher, Joel G , Fidler, Jeff L.

Mayo Clinic

RadioGraphics | June 8, 2018 | Volume: 38 | Issue: 4 | Pages: 1089-1107

10.1148/rg.2018170138 | PMID 29883267 Get It

Assessing the efficacy of peripherally acting mu-opioid receptor antagonists (PAMORAs) in the treatment of opioid-induced constipation
Chedid, Victor , Camilleri, Michael , Chedid, Victor G

Mayo Clinic

Gut | June 8, 2018 | Volume: 68 | Issue: 6 | Pages: 1133-1134

10.1136/gutjnl-2018-316824 | PMID 29884613 Get It

Mediterranean Diet, Its Components, and Amyloid Imaging Biomarkers
Vassilaki, Maria , Aakre, Jeremiah A. , Syrjanen, Jeremy A. , Mielke, Michelle M. , Geda, Yonas E. , Kremers, Walter K. , Alhurani, Rabe E., Staubo, Sara C., Petersen, Ronald C. , Lowe, Val J. , Jack, Clifford R. , Roberts, Rosebud O., Jack, Clifford R , Mielke, Michelle M , Geda, Yonas E , Machulda, Mary M. , Knopman, David S. , Kremers, Walter K

Mayo Clinic

Journal of Alzheimer’s Disease | June 8, 2018 | Volume: 64 | Issue: 1 | Pages: 281-290

10.3233/jad-171121 | PMID 29889074 Get It

Background: There is accumulating evidence suggesting that diet may play a role in preventing or delaying cognitive decline and dementia, but the underlying biological mechanisms are not well understood. Objectives: To examine the cross-sectional associations of the Mediterranean diet (MeDi) and its components with 11 C-PiB-PET scan measures of amyloid-β (Aβ) deposition. Methods: The study consisted of 278 Mayo Clinic Study of Aging participants 70+ years old, who were cognitively unimpaired (CU) at the time of completion of the Food Frequency Questionnaire (FFQ) and when they underwent PET imaging. Adherence to the MeDi was assessed by computing the MeDi score for each participant. All scans were performed after the FFQ completion; median [IQR] time between FFQ and Aβ PET was 3.5 (1.4) years. Z-scores were created for component, macro- and micronutrients measured. Linear and logistic regression models were adjusted for age, sex, education, apolipoprotein E (APOE) ɛ4 allele carrier status, time interval between the FFQ completion and PET scan, and total energy intake. Results: Participants’ median age at FFQ was 77.7 years (55.8% men; 26.6% with an APOE ɛ4 allele). Higher MeDi score (linear regression slope (beta):–0.035, p = 0.012; per standard deviation increase), vegetable intake (beta:–0.043, p = 0.002), intake of vitamin A (beta:–0.041, p = 0.003) or β-carotene (beta: –0.039, p = 0.005) from food sources and moderate alcohol consumption (beta: –0.074, p = 0.03) were associated with lower 11 C-PiB standardized uptake value ratio. Conclusion: Findings are consistent with previous studies suggesting that higher adherence to a MeDi pattern and higher vegetable consumption are associated with better neuroimaging biomarker profile. Prospective studies are needed to validate current findings.
Percutaneous epicardial pacing using a novel transverse sinus device
Vaidya, Vaibhav R. , Sugrue, Alan , Padmanabhan, Deepak , Killu, Ammar M. , Naksuk, Niyada , Al‐Masry, Anas Abudan , Isath, Ameesh , Pedersen, Joanne, Yngsdal, Lisa, Ladewig, Dorothy J., Friedman, Paul A. , Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | June 8, 2018 | Volume: 29 | Issue: 9 | Pages: 1308-1316

10.1111/jce.13661 | PMID 29882395 Get It

AbstractBackgroundTransvenous lead implantation has multiple drawbacks and complications that can be overcome by epicardial lead placement. We aimed to design percutaneously implanted epicardial leads that are anchored through the transverse sinus (TS).Methods and resultsWe designed a novel multielectrode pacing device with four bipole electrode pairs. The device is advanced through the TS, with both ends externalized out of the pericardium. We tested the prototype in one proof‐of‐concept and 5 additional acute canine experiments.The TS device recorded ventricular and atrial electrograms. The median amplitude of near‐field ventricular electrograms was 3.3 mA (IQR 2.0–4.3) and of near‐field atrial electrograms was 2.1 mA (IQR 1.3–2.2). The median ventricular threshold (N = 30) was 1.1 mA (IQR 0.7–3.1) at a median pulse width of 0.5 ms (IQR 0.5–0.5). The median atrial threshold (N = 10) was 2.4 mA (IQR 1.1–7.8) at a median pulse width of 0.5 ms (IQR 0.5–0.9). Right and left ventricular and atrial pacing morphologies were noted while pacing electrodes adjacent to these chambers. Simultaneous left (LV) and right ventricular (RV) pacing showed reduction in QRS duration from 116 ms (RV) and 105 ms (LV) to 91 ms. On necropsy, the device was located in the TS in all animals. There were TS abrasions in one animal, and no other acute complications.ConclusionsThis study highlights a novel approach to epicardial pacing harnessing the unique anatomy of the transverse sinus as an anchoring point. Placement of this novel transverse sinus device was safe and feasible, with acceptable atrial and ventricular thresholds.